Difficulty: Medium
Average Score: 76%
Practice
A 72-year-old man has just received midazolam for an endoscopic procedure of the upper gastrointestinal tract. Sedation is easily antagonized by flumazenil. Although the endoscopist asks to send the patient home in 1 hour, which of the following factors BEST explains why this patient should remain hospitalized for observation?
Correct answer
C
Rationale
The correct answer is C) Midazolam has a longer duration of action than flumazenil. This is because midazolam, a benzodiazepine, has a duration of action ranging from 1-6 hours, while flumazenil, a benzodiazepine receptor antagonist, has a much shorter duration of action of 0.5-1 hour. This means that even though flumazenil can antagonize the sedative effects of midazolam, once it wears off, there is a risk of the patient experiencing a resurgence of sedation due to the continued action of midazolam. Therefore, the patient should remain hospitalized for observation to monitor for any signs of resedation.
Regarding the other options:
A) Flumazenil has low affinity for benzodiazepine receptors: This is incorrect as flumazenil is actually a specific benzodiazepine receptor antagonist.
B) Flumazenil has moderate intrinsic agonist activity: This is incorrect as flumazenil acts as a competitive antagonist at the benzodiazepine receptor, not as an agonist.
D) Midazolam causes respiratory depression: While midazolam can cause respiratory depression, this is not the primary reason why the patient should remain hospitalized in this scenario. The key factor is the difference in duration of action between midazolam and flumazenil.
In an educational context, understanding the pharmacokinetics and pharmacodynamics of sedative medications like midazolam and flumazenil is crucial for healthcare professionals, especially those involved in procedural sedation and anesthesia. Knowing how these medications interact and their respective durations of action is vital for ensuring patient safety and appropriate post-procedural care. It highlights the importance of careful monitoring and individualized patient management based on drug properties.
Regarding the other options:
A) Flumazenil has low affinity for benzodiazepine receptors: This is incorrect as flumazenil is actually a specific benzodiazepine receptor antagonist.
B) Flumazenil has moderate intrinsic agonist activity: This is incorrect as flumazenil acts as a competitive antagonist at the benzodiazepine receptor, not as an agonist.
D) Midazolam causes respiratory depression: While midazolam can cause respiratory depression, this is not the primary reason why the patient should remain hospitalized in this scenario. The key factor is the difference in duration of action between midazolam and flumazenil.
In an educational context, understanding the pharmacokinetics and pharmacodynamics of sedative medications like midazolam and flumazenil is crucial for healthcare professionals, especially those involved in procedural sedation and anesthesia. Knowing how these medications interact and their respective durations of action is vital for ensuring patient safety and appropriate post-procedural care. It highlights the importance of careful monitoring and individualized patient management based on drug properties.